 Michael Puente
Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cataract | 4 | 2024 | 238 | 1.660 |
Why?
| | Keratoconus | 3 | 2025 | 23 | 1.300 |
Why?
| | Down Syndrome | 3 | 2025 | 525 | 1.210 |
Why?
| | Anesthesia, General | 2 | 2025 | 121 | 1.020 |
Why?
| | Riboflavin | 1 | 2025 | 15 | 0.880 |
Why?
| | Corneal Stroma | 1 | 2025 | 24 | 0.880 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2025 | 11 | 0.870 |
Why?
| | Nasolacrimal Duct | 1 | 2025 | 12 | 0.870 |
Why?
| | Photochemotherapy | 1 | 2025 | 39 | 0.870 |
Why?
| | Corneal Ulcer | 1 | 2025 | 20 | 0.860 |
Why?
| | Photosensitizing Agents | 1 | 2025 | 42 | 0.860 |
Why?
| | Abducens Nerve Diseases | 1 | 2024 | 13 | 0.860 |
Why?
| | Motion Pictures | 1 | 2024 | 20 | 0.850 |
Why?
| | Adenosine Deaminase | 1 | 2024 | 43 | 0.840 |
Why?
| | Cross-Linking Reagents | 1 | 2025 | 206 | 0.830 |
Why?
| | Strabismus | 1 | 2024 | 71 | 0.820 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2024 | 94 | 0.800 |
Why?
| | Prednisone | 1 | 2024 | 226 | 0.790 |
Why?
| | Ophthalmologists | 1 | 2023 | 21 | 0.790 |
Why?
| | Galactosemias | 1 | 2023 | 16 | 0.790 |
Why?
| | Arachnoid Cysts | 1 | 2023 | 10 | 0.770 |
Why?
| | Collagen | 1 | 2025 | 457 | 0.730 |
Why?
| | Papilledema | 1 | 2023 | 44 | 0.730 |
Why?
| | Cataract Extraction | 1 | 2023 | 120 | 0.710 |
Why?
| | Eye Banks | 1 | 2020 | 7 | 0.650 |
Why?
| | Corneal Transplantation | 1 | 2020 | 17 | 0.650 |
Why?
| | Stents | 1 | 2025 | 564 | 0.640 |
Why?
| | Homosexuality, Male | 1 | 2020 | 231 | 0.570 |
Why?
| | Corneal Topography | 3 | 2025 | 25 | 0.500 |
Why?
| | Healthcare Disparities | 1 | 2023 | 736 | 0.460 |
Why?
| | Cornea | 2 | 2025 | 154 | 0.400 |
Why?
| | Vision Disorders | 2 | 2025 | 179 | 0.370 |
Why?
| | Child | 8 | 2025 | 22739 | 0.300 |
Why?
| | Tomography | 2 | 2025 | 45 | 0.270 |
Why?
| | Retrospective Studies | 7 | 2025 | 17325 | 0.260 |
Why?
| | Infant | 4 | 2025 | 10090 | 0.240 |
Why?
| | Visual Acuity | 2 | 2025 | 490 | 0.220 |
Why?
| | Humans | 17 | 2025 | 145763 | 0.220 |
Why?
| | Hereditary Autoinflammatory Diseases | 1 | 2024 | 13 | 0.220 |
Why?
| | Patient Positioning | 1 | 2025 | 70 | 0.210 |
Why?
| | Esotropia | 1 | 2024 | 30 | 0.210 |
Why?
| | Infliximab | 1 | 2024 | 111 | 0.210 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2024 | 133 | 0.200 |
Why?
| | Child, Preschool | 5 | 2025 | 11868 | 0.200 |
Why?
| | Macular Edema | 1 | 2023 | 49 | 0.190 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2024 | 376 | 0.190 |
Why?
| | Rupture | 1 | 2023 | 91 | 0.190 |
Why?
| | Social Media | 1 | 2025 | 167 | 0.190 |
Why?
| | Ultraviolet Rays | 1 | 2025 | 385 | 0.180 |
Why?
| | Ophthalmology | 1 | 2023 | 120 | 0.180 |
Why?
| | Phacoemulsification | 1 | 2023 | 123 | 0.170 |
Why?
| | Aspirin | 1 | 2024 | 406 | 0.170 |
Why?
| | Diabetic Retinopathy | 1 | 2023 | 209 | 0.160 |
Why?
| | Glucocorticoids | 1 | 2024 | 532 | 0.160 |
Why?
| | Hospitals, Pediatric | 1 | 2023 | 558 | 0.150 |
Why?
| | Orbital Cellulitis | 1 | 2019 | 17 | 0.150 |
Why?
| | Health Status Disparities | 1 | 2023 | 321 | 0.150 |
Why?
| | Retinal Neoplasms | 1 | 2019 | 42 | 0.150 |
Why?
| | Retinoblastoma | 1 | 2019 | 47 | 0.150 |
Why?
| | Canada | 1 | 2020 | 432 | 0.150 |
Why?
| | Male | 8 | 2025 | 73003 | 0.140 |
Why?
| | Eye Injuries, Penetrating | 1 | 2017 | 19 | 0.130 |
Why?
| | Eye Foreign Bodies | 1 | 2017 | 23 | 0.120 |
Why?
| | Play and Playthings | 1 | 2017 | 35 | 0.120 |
Why?
| | Orbit | 1 | 2017 | 66 | 0.120 |
Why?
| | Female | 7 | 2025 | 79035 | 0.120 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2016 | 53 | 0.120 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2017 | 90 | 0.120 |
Why?
| | Colorado | 2 | 2023 | 4556 | 0.110 |
Why?
| | Neonatal Screening | 1 | 2016 | 179 | 0.100 |
Why?
| | Retinopathy of Prematurity | 1 | 2016 | 181 | 0.100 |
Why?
| | Wounds, Gunshot | 1 | 2017 | 258 | 0.100 |
Why?
| | Adolescent | 4 | 2025 | 22573 | 0.090 |
Why?
| | Risk Factors | 2 | 2025 | 10917 | 0.090 |
Why?
| | Young Adult | 2 | 2025 | 14251 | 0.080 |
Why?
| | Treatment Outcome | 1 | 2025 | 11793 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2602 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6085 | 0.070 |
Why?
| | Adult | 2 | 2025 | 40872 | 0.050 |
Why?
| | United States | 1 | 2020 | 16123 | 0.050 |
Why?
| | Communication Barriers | 1 | 2023 | 130 | 0.040 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2016 | 24 | 0.030 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2016 | 75 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1512 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5922 | 0.020 |
Why?
| | Birth Weight | 1 | 2016 | 517 | 0.020 |
Why?
| | Ultrasonography | 1 | 2017 | 788 | 0.020 |
Why?
| | Gestational Age | 1 | 2016 | 989 | 0.020 |
Why?
| | Weight Gain | 1 | 2016 | 561 | 0.020 |
Why?
| | Models, Statistical | 1 | 2016 | 672 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 2000 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4329 | 0.020 |
Why?
| | Algorithms | 1 | 2016 | 1850 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2770 | 0.010 |
Why?
| | Cohort Studies | 1 | 2016 | 6032 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2016 | 6464 | 0.010 |
Why?
|
|
Puente's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|